Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study

BACKGROUND: Gram-negative bacteria mediated gemcitabine resistance in pre-clinical models. We determined if intratumoural lipopolysaccharide (LPS) detection by immunohistochemistry is associated with outcome in advanced pancreatic ductal adenocarcinoma (PDAC) treated with gemcitabine and non-gemcita...

Descripción completa

Detalles Bibliográficos
Autores principales: Guenther, Michael, Haas, Michael, Heinemann, Volker, Kruger, Stephan, Westphalen, Christoph Benedikt, von Bergwelt-Baildon, Michael, Mayerle, Julia, Werner, Jens, Kirchner, Thomas, Boeck, Stefan, Ormanns, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591915/
https://www.ncbi.nlm.nih.gov/pubmed/32830200
http://dx.doi.org/10.1038/s41416-020-01029-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591915/
https://www.ncbi.nlm.nih.gov/pubmed/32830200
http://dx.doi.org/10.1038/s41416-020-01029-7

Ejemplares similares